methionine has been researched along with Delusional Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kowalczyk, M; Kowalski, J; Kucia, K; Owczarek, A; Paul-Samojedny, M; Suchanek, R | 1 |
| Mishanich, II; Popovich, SI; Rostoka, LM; Turianitsa, IM | 1 |
2 other study(ies) available for methionine and Delusional Disorder
| Article | Year |
|---|---|
BDNF val66met polymorphism is associated with age at onset and intensity of symptoms of paranoid schizophrenia in a Polish population.
Topics: Adult; Age of Onset; Analysis of Variance; Brain-Derived Neurotrophic Factor; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Middle Aged; Poland; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Schizophrenia, Paranoid; Sex Factors; Valine | 2013 |
[Amino acid reserves of the blood in patients with schizophrenia and their correction in insulin coma].
Topics: Amino Acids; Convulsive Therapy; Glutamates; Glutamic Acid; Humans; Methionine; Schizophrenia, Paranoid | 1989 |